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Abstract
Introduction: The development of the intestinal gut is largely influenced by early nutrition. Infant immunity is
challenged by the exposure of the gut to foreign bodies, which mediate inflammation of the gut. This study
assessed the levels of gut inflammation in relation to the percentage of breastmilk consumed/the exclusivity of
breastfeeding in South African infants. This is the first study to examine markers of gut inflammation in infants
in relation to exclusivity of breastfeeding measured by a gold standard method.
Methodology: Twenty-four black South African infants were included in this study. The categorization of
different degrees of exclusivity of breastfeeding was made using an objective gold standard method developed
by the International Atomic Energy Agency (deuterium dilution method). Markers of gut inflammation were
measured noninvasively by sampling stool from the infants averaging 6 months of age. Gut inflammation was
investigated by running multiple Droplet Digital (Bio-Rad, Hercules, CA) polymerization chain reaction tests
profiling a panel of five mRNA probes (interleukin-8 [IL-8], S100 calcium-binding protein A8 [S100A8], Toll-
like receptor-4, human leukocyte antigen on chromosome 6 region 6p21.31, and defensin alpha 8). These
mRNA biomarkers expressions were tested in proportion to number of glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) copies as GAPDH is constitutively expressed in most cells.
Results: Two previously described robust mRNA markers of gut inflammation (S100A8 and IL-8) were found
to correlate significantly to the percentage of breastmilk intake (r2 = 0.4302, p = 0.0004 and r2= 0.3633,
p= 0.002, respectively) in the range of 75–100% in 22 samples analyzed.
Conclusions: This study using objective methodology has shown that higher percentages of breastmilk intake
are associated with significantly lower levels of gut inflammation. This further supports the health benefits
observed in exclusively breastfed infants.
Introduction
The gut, the largest immunological organ in thebody, plays a significant role in protection against in-
fection. A better understanding of the gut will provide better
understanding of human health.1 The diet of the infant plays
an influential role in colonization of the gut, which in turns
impacts child development and health.2 Gut colonization, or
the acquisition of the early microbiota, is strongly influenced
by environmental factors such as the delivery mode, envi-
ronment, hygiene, diet, antibiotics, and gestational age.3–5
Breastmilk provides a favorable microbial colonization of the
gut.6–8 Studies investigating the feces of young infants re-
vealed the presence of meconium microbiota in newborn in-
fants that suggest intrauterine origin.7 Furthermore, an increase
of staphylococci bacteria has been reported in breastfed infants
in comparison with formula-fed infants, which assists in gut
colonization.8 Breastfeeding has been shown to protect infants
against infectious and immuno-inflammatory diseases9 and
consequently to influence the health of children.10
Human breastmilk has important protective benefits against
bacterial infections due to its immune properties.9 Evidence
exists that growth faltering in Gambian infants was associ-
ated with impaired gut intestinal barrier function.11 Breast-
feeding induces a gut microbiota rich in bifidobacteria, which
contribute to the development of the immune response and
the lower incidence of diarrhea and allergy in breast-fed in-
fants compared with formula-fed infants.12 A recent study
comparing gut microbiota in breastfed and formula-fed Ko-
rean infants showed an higher, nearing doubled, percentage
increase of bifidobacteria in breastfed infants in comparison
with formula-fed infants.13 Further suggestions of underlying
gut perturbations leading to diarrhea are found in a South
African study in a population with similar disadvantages as
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ours that showed that in both human immunodeficiency virus
(HIV)-exposed and HIV-unexposed infants, those infants
who were exclusively breastfed had fewer, shorter episodes
of diarrhea compared with those infants who were mixed fed
or never breastfed.14
Various methods are available to determine the degree of
gut inflammation in adults and children. In order to measure
this in infants, the only feasible method is a noninvasive
method. Various noninvasive methods do exist, including,
among others, measuring the ratio of lactulose:mannitol in
urine samples15 and measuring fecal calprotectin.16
In this study we selected a sensitive methodology of ex-
tracting human mRNA from exfoliated cells shed from the
gut and then a digital drop polymerization chain reaction for
maximum amplification. Five inflammatory markers were
then selected from a range of inflammatory biomarkers used
in previous studies.17–19
Earlier studies examining the impact of exclusive breast-
feeding on the gut have been hampered by the inaccuracy of
the categorization of exclusive breastfeeding because this is
traditionally based on maternal recall. The stable isotope
technique (deuterium dilution method) recently developed
under the auspices of the International Atomic Energy
Agency20 offers researchers the ability to accurately assess
exclusive breastfeeding. Studies in India and Cameroon that
examined exclusive breastfeeding rates using the deuterium
dilution method as well as maternal recall found a large
discrepancy between the two, with the maternal recall con-
siderably over-reporting exclusive breastfeeding.21,22
This deuterium dilution method, which involves deuterium
oxide administered to the mother, has made it possible to
distinguish between an infant’s breastmilk intake and intake
from other sources such as formula, cow’s milk, teas, juice,
and water. This facilitates an objective determination of ex-
clusive breastfeeding and in this study allowed us to deter-
mine different levels of percentages of breastmilk intake as
proxies of different degrees of exclusivity of breastfeeding.
This technique measures the volumes of breastmilk output by
the mother and thus the milk intake by the infant. In this
methodology the deuterated water consumed by the mother
subsequently mixes with the mother’s body water, and this
equilibrates and is distributed uniformly in the body.23 A
breastfeeding infant then consumes the deuterated water in
his or her mother’s breastmilk. This technique requires saliva
samples to be collected from the mother and infant before the
dose is given and over a period of 14 days after the initial dose
is given to the mother. The saliva is subsequently analyzed
for deuterium levels, which are fitted to a model for water
turnover in the mother and infant and can be used to deter-
mine what percentage of the infant’s intake was breastmilk.20
This study therefore set out to describe the influence of
exclusivity of breastfeeding (objectively measured) on
markers of gut inflammation measured using noninvasive
methodology.
Materials and Methods
Study population
Mother–infant pairs were participants of a parent study
determining breastmilk intake using the deuterium dilution
method. The inclusion criteria of the parent study, which re-
cruited 100 mother–infant pairs, required infants to be term
infants from well, breastfeeding African mothers. Ethical
approval was obtained from the Biomedical Research Ethics
Committee, University of KwaZulu-Natal (protocol number
BE211/11). Of these 100 mothers a convenience sample of the
first 35 mothers and infants was recruited for co-enrollment in
this substudy, during the period January–September 2013.
Additional consent was obtained from the mothers to partic-
ipate in the substudy, which involved collection of a stool
sample from the infant between 5 and 6 months of age.
The study was conducted in a primary healthcare center
approximately 10km from the Durban city center in South
Africa. This center serves the community of Cato Manor,
which has an estimated population of about 93,000 people,
many of whom are unemployed and reside in informal
dwellings.24 This typical urban disadvantaged community was
used for the study as it represented infants who are at risk
because of poor sanitation and water supply as well as inad-
equate nutrition and therefore a critical population in whom
determining the influence of breastfeeding is important.
Sample collection
Stool samples were collected fresh from plastic-lined di-
apers and transferred to 2-mL BD (Franklin Lakes, NJ)
cryovials using disposable wooden sticks. Samples were
frozen within 6–8 hours of collection and stored at -80C
until analysis. Stool samples were shipped and processed
using methodology described by Agapova et al.17 by the
laboratory of one of the co-authors (M.M.) at the University
of Washington (St. Louis, MO).
Saliva was collected using cotton wool swabs. The swabs
were placed into a syringe and drained into test tubes. The
samples were collected before consumption of deuterated
water and after consumption over a period of 14 days for
mother and child.20
Biomarker analysis
Frozen stool (pea-sized) (200mg) was transferred to a 2-mL
tube containing seven to 10 2.3-mm-diameter zirconium/silica
beads (Research Products International Corp., Mt. Prospect,
IL) over dry ice. Easy NucliSENS MAGlysis buffer (bio-
Me´rieux, Boxtel, The Netherlands) (1mL) was added, and the
mixture was ‘‘bead-beated’’ with a FastPrep-24 tissue ho-
mogenizer (MP Biomedicals, Santa Ana, CA) for two con-
secutive 45-second runs and then centrifuged (at 13,200 rpm
for 10 minutes). Supernatant (200lL) was used for automated
RNA isolation by the NucliSENS easyMag extraction in-
strument (bioMe´rieux) following the manufacturer’s instruc-
tions. Samples were quantified on a NanoDrop (Thermo
Fisher Scientific, Waltham, MA) to confirm presence and
concentration of the total RNA.
Droplet Digital polymerization chain reaction (ddPCR),
a highly sensitive methodology, was performed using the
QX100 Droplet Digital system (Bio-Rad, Hercules, CA),
which accurately provides the absolute quantification of the
target sequences. The following biomarkers were selected for
analysis: interleukin 8 (IL-8), S100 calcium-binding protein
A8 (S100A8), Toll-like receptor-4 (TLR-4), human leukocyte
antigen on chromosome 6 region 6p21.31 (HLA-DR), and
defensin alpha 8 (DEFA5). These markers were selected based
on literature searches and evidence gained from prior studies
performed at the laboratory of co-authorM.M. Glyceraldehyde
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3-phosphate dehydrogenase (GAPDH) was selected as a
standardized measure of the total human mRNA in the
samples.25
Reaction mixtures of 20lL were prepared using 6lL of
RNA (20 ng/lL or less), 10lL of ddPCR Supermix for Probes
(Bio-Rad), 0.08lL of SuperScript III reverse transcriptase
(200U/lL; Invitrogen, Thermo Fisher Scientific), 0.16lL of
RNaseOUT (40U/lL; Invitrogen), 1lL of 20· TaqMan
gene expression assay (Applied Biosystems, Inc., Thermo
Fisher Scientific), and 2.76 (simplex) or 1.76 (duplex) lL of
RNase-free water. Taqman probes were labeled with either
VIC, a proprietary green fluorescent dye (Life Technolo-
gies, Grand Island, NY) or FAM (6-carboxyfluorescein). All
samples were tested in duplicate. Droplets were generated
according to the manufacturer’s guidelines with the QX100
Droplet Digital generator before cycling in a C1000 Touch
thermal cycler (Bio-Rad) at 50C (30 minutes), 95C
(10 minutes), 40 cycles of 94C (30 seconds) followed by
60C (1 minute), and 98C (10 minutes). Plates were held at
4C between amplification and droplet reading.
The data from the QX100 Droplet Digital reader was an-
alyzed with QuantaSoft (Kosice, Slovakia) software. Fluor-
escent droplets were deemed positive by manually set
thresholds based on results from negative control wells con-
taining RNase-free water instead of RNA and were stan-
dardized for each assay run.
The mRNA expression for each biomarker was standard-
ized against GAPDH concentrations. GAPDH is used in many
experimental investigations as the GAPDH gene is often sta-
ble and constitutively expressed at high levels in most tissues
and cells. Comparisons between mRNA from infants who
were exclusively breastfeeding and mixed feeding were made
using breastmilk intake values. Pearson’s correlation coeffi-
cients and t tests were performed using Microsoft (Redmond,
Wa) Excel and OpenEpi (www.openepi.com) software.
Results
All infants were born at full term. Normal vaginal delivery
was the main mode of delivery. Infants’ birth weights ranged
from 2.5 to 4.5 kg. Half the cohort of infants were born to
HIV-infected mothers who as per standard South African
Ministry of Health guidelines were all receiving antiretroviral
therapy, whereas the remaining infants were unexposed. CD4
counts in the HIV-infected mothers ranged from 150 to 760
cells/cm3 of blood. Exposed infants received nevirapine for
their first 6 weeks of life. As per South African guidelines, all
HIV-exposed infants are tested by DNA-polymerase chain
reaction for HIV infection; none of the HIV-exposed infants
was infected.
Breastmilk intake percentages ranged from 75% to 100%,
with the intake being a percentage of the total dietary intake.
Of the 35 infants enrolled in the study, 11 infants were not
included in this study because of incomplete data: six were
missing breastmilk intake values, and five had incomplete
biomarker data. The 11 infants not included in the study did
not differ in any of the variables examined when compared
with the 24 included in the study.
Of the five biomarkers analyzed only two (S100A8 and IL-
8) were robustly expressed on all 24 samples with readable
GAPDH values. Two infants had values that were significant
outliers (more than 4 standard deviations from the mean), and
therefore the biomarker results for these two infants were
removed in all the analyses. Plotting of S100A8/GAPDH and
IL-8/GAPDH with breastmilk intake values revealed signif-
icant negative correlations: r2 = 0.4302, p = 0.0004 and
r2 = 0.363, p = 0.002, respectively (Fig. 1). HLA-DRA and
TLR-4 (data not shown) were only detected in 15 samples but
showed similar significant negative correlations with breast-
milk intake percentage: HLA-DRA, r2 = 0.201, p= 0.03;
TLR-4, r2 = 0.300, p = 0.003. The fifth biomarker (DEFA5)
was not adequately detected in relation to GAPDH levels in
any of the 24 samples.
To further test the association of breastmilk intake per-
centages with the two biomarkers, S100A8 and IL8, breast-
milk intake percentages were divided into two groups: the top
11 values and the lower 11 values (i.e., ‡88% and <88%).
Means of the S100A8 (0.42– 0.66 and 1.94 – 1.70, respec-
tively) and IL-8 (0.70 – 1.27 and 2.24– 1.97, respectively)
markers were then compared with these percentage breast-
milk intake categories using a two-sample independent t test
and gave significant p values at the 95% confidence level
( p = 0.0161 and p = 0.0415, respectively).
These biomarkers showed no correlation with all other
variables collected: hygiene, HIV exposure, delivery mode,
age, gender, and birth weight.
FIG. 1. Target/glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) expression in relation to percentage breast-
milk intake. The mRNA markers (top panel) interleukin-8
(IL-8) and (bottom panel) S100 calcium-binding protein A8
(S100A8) are inversely correlated with the percentage of
breastmilk intake in this cohort of 6-month-old infants.
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Discussion
Our examination of markers of gut inflammation showed
minimal to no inflammation in the infants who had high
levels of percentage of breastmilk intake, and a dose–re-
sponse was seen with slightly higher levels of inflammation,
the lesser the percentage of breastmilk intake. Our results
confirm the findings of previous studies. Decreased inflam-
mation has been previously found in infants who are exclu-
sively breastfed compared with mixed fed at 3 months of
age.26 Exclusive breastfeeding has previously been associ-
ated with less low-grade inflammation, as estimated by serum
fibrinogen levels in healthy children and adolescents reported
to be exclusively breastfed.27
The most important strength of this study is that we ac-
curately differentiated different degrees of exclusivity of
breastfeeding/levels of percentage of breastmilk intake us-
ing the gold-standard deuterium dilution method. Another
strength of our study was that we successfully extracted hu-
man DNA/RNA using a noninvasive method of stool sam-
pling in infants as young as 6 months of age. Furthermore,
markers of gut inflammation were successfully expressed
using stool samples. The success of this methodology was
further verified using GAPDH as a means of normalization
for interspecimen differences in concentration of human
mRNA. There are very few studies that have successfully
validated noninvasive mRNA technology. We were, more-
over, able to validate this methodology in infants.
The observation made in this study that the lower the
percentage of breastmilk intake, the greater the risk of gut
inflammation is important as it provides further mechanistic
evidence to suggest why exclusive breastfeeding results in
fewer infections and less perturbations of immunity. It pro-
vides additional information for policy makers to advocate
for the promotion of exclusive breastfeeding.
A limitation of this study is that although we had longi-
tudinal data on other factors that could influence the gut, such
as antibiotic exposure, significant diarrhea episodes, etc.,
because of the small sample size we obviously could not
control for these other variables. Nevertheless, the results
indicate that the exclusivity of breastfeeding remains a strong
influence regardless of intervening events that could have
affected the gut milieu. An additional limitation is that there
was a small variation in breastfeeding practices, which lim-
ited the ability to show an association over a wide range. We
recommend that follow-up studies should include children
who also receive no breastmilk or minimal breastmilk to
provide a better understanding of the influence of exclusivity
of breastfeeding on gut inflammation biomarkers.
Conclusions
This study using objective methodology has shown that
higher percentages of breastmilk intake are associated with
significantly lower levels of gut inflammation as detected by
biomarkers. These results therefore provide further mecha-
nistic support for the health benefits observed in exclusively
breastfed infants.
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